Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Cote

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Endocrine Oncology|April 25, 2015
Treating medullary thyroid cancer in the age of targeted therapyMaria E Cabanillas, Mimi I Hu, Camilo Jimenez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2006
Polypyrimidine tract binding protein and Notch1 are independently re-expressed in gliomaHannah C Cheung, Lynda J Corley, Gregory N Fuller, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2007
Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancerLibero Santarpia, Adel K El-Naggar, Gilbert J Cote, et al.
Molecular Carcinogenesis|October 7, 2011
PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesisDaisy I Izaguirre, Wen Zhu, Tao Hai, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2015
Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupKeith C Bible, Gilbert J Cote, Michael J Demeure, et al.
Brain : a Journal of Neurology|June 10, 2009
Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell linesHannah C Cheung, Tao Hai, Wen Zhu, et al.
Molecular Cancer Therapeutics|September 8, 2021
Hallmarks of RET and Co-occuring Genomic Alterations in <i>RET</i>-aberrant CancersJacob J Adashek, Aakash P Desai, Alexander Y Andreev-Drakhlin, et al.
Surgery|November 11, 2017
Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institutionIoannis Christakis, Wei Qiu, Samuel M Hyde, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2018
A Homozygous RET K666N Genotype With an MEN2A PhenotypeTania Jaber, Samuel M Hyde, Gilbert J Cote, et al.
Molecular Cancer Research : MCR|December 16, 2018
Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid CancerRozita Bagheri-Yarmand, Krishna M Sinha, Ling Li, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Endocrine Oncology|April 25, 2015
Treating medullary thyroid cancer in the age of targeted therapyMaria E Cabanillas, Mimi I Hu, Camilo Jimenez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2006
Polypyrimidine tract binding protein and Notch1 are independently re-expressed in gliomaHannah C Cheung, Lynda J Corley, Gregory N Fuller, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2007
Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancerLibero Santarpia, Adel K El-Naggar, Gilbert J Cote, et al.
Molecular Carcinogenesis|October 7, 2011
PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesisDaisy I Izaguirre, Wen Zhu, Tao Hai, et al.
The Journal of Clinical Endocrinology and Metabolism|September 30, 2015
Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupKeith C Bible, Gilbert J Cote, Michael J Demeure, et al.
Brain : a Journal of Neurology|June 10, 2009
Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell linesHannah C Cheung, Tao Hai, Wen Zhu, et al.
Molecular Cancer Therapeutics|September 8, 2021
Hallmarks of RET and Co-occuring Genomic Alterations in <i>RET</i>-aberrant CancersJacob J Adashek, Aakash P Desai, Alexander Y Andreev-Drakhlin, et al.
Surgery|November 11, 2017
Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institutionIoannis Christakis, Wei Qiu, Samuel M Hyde, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2018
A Homozygous RET K666N Genotype With an MEN2A PhenotypeTania Jaber, Samuel M Hyde, Gilbert J Cote, et al.
Molecular Cancer Research : MCR|December 16, 2018
Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid CancerRozita Bagheri-Yarmand, Krishna M Sinha, Ling Li, et al.
Pageof 7